Your browser doesn't support javascript.
loading
Locked and Loaded: Ruthenium(II)-Capped Cucurbit[n]uril-Based Rotaxanes with Antimetastatic Properties.
Sojka, Martin; Fojtu, Michaela; Fialova, Jindriska; Masarik, Michal; Necas, Marek; Marek, Radek.
Afiliação
  • Sojka M; Department of Chemistry, Faculty of Science , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
  • Fojtu M; CEITEC-Central European Institute of Technology , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
  • Fialova J; CEITEC-Central European Institute of Technology , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
  • Masarik M; Department of Pathological Physiology, Faculty of Medicine , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
  • Necas M; Department of Physiology, Faculty of Medicine , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
  • Marek R; Department of Physiology, Faculty of Medicine , Masaryk University , Kamenice 5 , CZ-62500 Brno , Czechia.
Inorg Chem ; 58(16): 10861-10870, 2019 Aug 19.
Article em En | MEDLINE | ID: mdl-31355636
ABSTRACT
We report here the first coupling of Ru(II) units with cucurbit[6/7]uril-based pseudorotaxane ligands meant for biological application. The resulting ruthenium-capped rotaxanes were fully characterized, and a structure of one supramolecular system was determined by X-ray diffraction. Because the biological properties of Ru-based metallodrugs are tightly linked to the ligand-exchange processes, the effect of salt concentration on the hydrolysis of chlorides from the Ru(II) center was monitored by using 1H NMR spectroscopy. The biological activity of Ru(II)-based rotaxanes was evaluated for three selected mammalian breast cell lines, HBL-100, MCF-7, and MDA-MB-231. The antimetastatic activity of the assembled cationic Ru(II)-rotaxane systems, evaluated in migration assays against MCF-7 and MDA-MB-231 cell lines, is notably enhanced compared to that of RAPTA-C, a reference that was used. The indicated synergistic effect of combining Ru(II) with a pseudorotaxane unit opens a new direction in searching for anticancer supramolecular metallodrugs.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Inorg Chem Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Inorg Chem Ano de publicação: 2019 Tipo de documento: Article